Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.2 (
alanine aminotransferase
)
26,722
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To study the influence of hepatic metallothionein (MT) on the hepatotoxic response to carbon tetrachloride (CCl4), adult male rats were pretreated with a 10 mg X kg-1 dose of zinc (Zn) 24 h prior to CCl4 (i.p., l mL X kg-1) treatment. Zn pretreatment increased the hepatic MT concentrations markedly and reduced the magnitudes of the CCl4-induced reduction of cytochrome P450 concentration as well as elevation of serum
alanine aminotransferase
and aspartate aminotransferase activities when determined at 4 or 24 h following CCl4 treatment. Treatment of Zn-exposed animals with CCl4 also resulted in significant reduction of the concentrations of hepatic MT (as determined by the
cadmium
-saturation method) as well as cytosolic Zn. Sephadex G-75 chromatographic study of hepatic cytosols showed that MT-bound Zn was selectively depleted by CCl4 exposure. Moreover, it was demonstrated that CCl4, after metabolic activation, reduced the
cadmium
binding capacity of Zn-induced hepatic MT in vitro. To examine the possible protective effect of Zn independent of induction of MT synthesis, CCl4 was administered 2 h following Zn pretreatment and the hepatotoxic response was examined 4 h later. This study revealed limited protection by Zn prior to the induction of MT synthesis. These data further support a role of MT in the modulation of CCl4 hepatotoxicity.
...
PMID:Interaction of metallothionein and carbon tetrachloride on the protective effect of zinc on hepatotoxicity. 379 Oct 46
Cadmium
effects on the bluegill sunfish (Lepomis macrochirus) were assessed histologically and biochemically and the effects were compared with effects on the ecologically relevant parameters of growth and survival. Growth and survival were monitored and tissues were removed for histopathological assessment of toxicant effects in a 163-day chronic exposure. The biochemical effects of
cadmium
were determined in a 32-day subchronic exposure. Exposure of fish to
cadmium
in hard water (363 mg Cd/liter) caused significant reductions in growth at 3.9 and 12.7 mg Cd/liter. Mortality was significantly increased over controls at 12.7 mg Cd/liter. Histopathological lesions were observed in gill tissue from fish exposed to 3.9 and 12.7 mg Cd/liter at all times during the chronic exposure. No histopathological lesions were observed in any internal organ during this exposure. In a 32-day subchronic exposure,
cadmium
caused significant increases in serum acid phosphatase and N-acetyl-beta-d-glucosaminidase activities. Serum aspartate and
alanine transaminase
and lactate dehydrogenase activities were not increased by
cadmium
exposure. Liver lysosomal membranes were destabilized by
cadmium
exposure. This indicates an alteration in lysosome function. The utility of biochemical and histological procedures for estimating safe concentrations of environmental pollutants are discussed.
...
PMID:The histological and biochemical effects of cadmium exposure in the bluegill sunfish (Lepomis macrochirus). 395 30
Two serum enzymes which originate from the liver under different circumstances were examined as potential biological indicators in serum for
cadmium
toxicity. The first of those is an enzyme that leaks from damaged liver cells. The second is an enzyme that is secreted by the normal functioning liver. Cadmium chloride was injected s.c. into male and female rats of the Wistar strain (8, 15 and 22 weeks old), at doses of 1.0, 1.5 and 2.0 mg Cd/kg body weight (in total 18 groups). Cholinesterase (CHE; EC 3.1.1.8) activity in serum was found to decrease with time after the administration of a single injection of
cadmium
chloride and, in all experimental groups, was significantly lower than the control values on day 2 after the injection. Glutamic pyruvic transaminase (
GPT
;
EC 2.6.1.2
) activity in serum, however, increased only in the oldest group of males receiving the high dose levels of
cadmium
. A time-course experiment in which male and female rats 15 weeks of age were administered 1.5 mg Cd/kg body weight showed that the serum CHE activity started to decrease on day 1 after the injection, attained the lowest level on days 2 and 3, and then recovered almost to control levels on day 5. On the other hand, the
GPT
activity remained at or less than control values throughout the experimental period. The results indicate that CHE activity in serum is a sensitive biological indicator for
cadmium
toxicity.
...
PMID:Depression of serum cholinesterase activity by cadmium. 404 26
Resistance to the lethal action of
Cd2+
produced in mice was maintained for 6 to 24 hr after pretreatment with 1/10 of the challenge
Cd2+
doses as shown by an increased oral LD50. Pretreatment 24 hr prior to the challenge doses was most effective. In addition, 1/20 to 1/7 of the challenge doses was necessary to acquire the tolerance to the acute oral toxicity of
Cd2+
. The largest effect was found for pretreatment with 1/7 of the challenge doses. Acute liver injury at 24 hr after challenge with a large dose of
Cd2+
(100 mg
Cd2+
/kg, p.o.) was markedly reduced by pretreatment with a small dose of the cation (15 mg
Cd2+
/kg, p.o.) 24 or 48 hr prior to the challenge dose as shown by a marked reduction in serum GOT and
GPT
activities and the reversal of histopathological changes. The elevated serum urea nitrogen at 4 hr after the
Cd2+
challenge was reduced by pretreatment 6 to 24 hr prior to the challenge dose. In spite of the increased urea nitrogen 4 hr after the
Cd2+
challenge, no morphological alterations were observed in the kidney at 24 hr. Serum Alp activity was not significantly influenced by the
Cd2+
challenge. Glucose in serum was increased by the administration of a small dose of
Cd2+
, but was unaffected by a large dose. Decreases in hepatic RNA and DNA concentrations at 24 hr after the
Cd2+
challenge were prevented by pretreatment 24 or 48 hr prior to the challenge dose. Potentiation of hexobarbital sleep time was observed at 6 or 24 hr after a small dose of
Cd2+
. Nevertheless, further potentiation at 24 hr after the
Cd2+
challenge (75 mg
Cd2+
/kg, p.o., in this case) was reduced by pretreatment 24 hr prior to the challenge dose. A major target organ for the acute oral toxicity of
Cd2+
was the liver rather than the kidney.
...
PMID:Defense mechanisms against cadmium toxicity I. A biochemical and histological study of the effects of pretreatment with cadmium on the acute oral toxicity of cadmium in mice. 620 99
The effect of a single intravenous (i.v.) injection of
cadmium
nitrate was investigated in livers of male Wistar rats. A significant increase in liver weight, accompanied by an elevation of total hepatic DNA content was observed. DNA synthesis as measured by the incorporation of [3H]thymidine, was found to be 6 times greater than the control, at 24 h after treatment, and remained elevated over a period of 72 h. This elevation in DNA synthesis was not a consequence of cell necrosis, since no increase of serum glutamate-
pyruvate transaminase
(SGPT) activity was observed.
...
PMID:Stimulation of DNA synthesis after a single administration of cadmium nitrate. 652 20
Pretreatment with nickel has earlier been shown to protect against
cadmium
intoxication. The effect of
cadmium
pretreatment on the nephro- and hepatotoxicity of nickel has been investigated. The administration of
cadmium
(6 mg/kg, i.m., once) to rats significantly enhanced urinary excretion of ALP, LDH, GOT, amino acids and proteins and increased the activity of serum ALP, GOT, and
GPT
, while the administration of nickel (6 mg/kg, i.p., 3 days) altered these parameters less significantly. These changes in urine and serum were used as a measure of renal and hepatic damage. The administration of nickel for three days, one week after
cadmium
treatment, caused significantly more marked enzymuria, aminoaciduria, proteinuria and an increase in the activity of serum enzymes than induced by either of them individually. However,
cadmium
pretreatment had no influence on urinary excretion or hepatic uptake of nickel, but increased renal uptake of nickel on the fourth day. The results suggest that
cadmium
enhances the nephro- and hepatotoxicity of nickel.
...
PMID:Effect of cadmium pretreatment on nickel toxicity. 653 85
Rats were administered ferrous sulfate,
cadmium
chloride, or sodium vanadate alone and in combination with carbon tetrachloride (CCl4) to determine if lipid peroxidation is associated with the toxicity of the three metals and to determine if there is an interaction between these metals and CCl4 in producing lipid peroxidation and hepatotoxicity. Expired ethane was used as an index of lipid peroxidation while serum
alanine aminotransferase
(
ALT
) and histopathology were used to assess liver damage. Lipid peroxidation did not appear to be associated with the hepatotoxicity of
cadmium
since no measurable increase in ethane production was observed when serum
ALT
concentrations were doubled relative to controls.
Cadmium
did not increase ethane when administered with CCl4 and the increase in
ALT
was additive. Iron and vanadate produced small significant increases in ethane production but no increase in
ALT
and only minor histopathologic changes, yet potentiated lipid peroxidation and liver damage when administered with CCl4. Thus, Cd did not produce lipid peroxidation and did not potentiate the lipid peroxidation and hepatotoxicity of CCl4, while iron or vanadate which produced lipid peroxidation alone potentiated the lipid peroxidation and hepatotoxicity of CCl4.
...
PMID:Interaction of metals and carbon tetrachloride on lipid peroxidation and hepatotoxicity. 655 84
Twenty-one male rabbits were divided into three groups: rabbits of two groups were given pelleted food containing
cadmium
chloride at a dose level of 300 micrograms Cd/g over periods of 44 or 19 weeks. Rabbits of the last group were given ordinary commercial pelleted food and served as controls.
Cadmium
increased urinary protein and amino acid by week 19 and increased it to a remarkably high level by week 44. After cessation of
cadmium
exposure, rabbits of the first group (44 weeks exposure group) showed only little recovery from
cadmium
health effects: proteinuria and aminoaciduria were slightly improved. Depressed hepatic functions were also slightly improved, but did not return to the control level in 24 weeks. Fat and bone metabolism also remained depressed below the control level. Anemia did not also readily recover. On the other hand, rabbits of the second group (19 weeks exposure) recovered from the effects of
cadmium
: proteinuria and aminoaciduria in most animals disappeared soon after the end of
cadmium
exposure, plasma
GPT
fell after 1 week, and hemoglobin and hematocrit returned to normal in 6-11 weeks. The above results show that after cessation of
cadmium
exposure, mild
cadmium
-induced health effects were reversible in a short period, while more severe effects were not readily reversible. High performance liquid chromatographic (HPLC) profiles of renal and hepatic
cadmium
-thionein (Cd-MT) during and after exposure to
cadmium
showed no correlation to the degree of
cadmium
health effects, and therefore, did not help to elucidate mechanisms of the recovery from
cadmium
-induced health effects, probably because
cadmium
not bound with metallothionein (non-MT-Cd) is responsible for inducing renal effects.
...
PMID:Reversibility of cadmium-induced health effects in rabbits. 673 56
The role of zinc (Zn) in preventing
cadmium
(Cd)-induced alterations of liver function and carbohydrate metabolism was studied in female rats. The animals were divided into four groups. To the diet for Group I was added 200 micrograms Cd/g of diet, to that for Group II was added 200 micrograms Zn/g of diet, and to that for Group III were added 200 micrograms Cd/g and 200 micrograms Zn/g of diet. Group IV was the control group fed normal diet. At the 11th, 26th, and 40th week of exposure, one-third of each group of animals were sacrificed and serum
GPT
and ALP activities, and glucose and insulin levels were measured. At the 26th and 40th week, serum
GPT
activity of Group I was significantly higher compared with those of Groups III and IV, and the serum glucose value of Group I was lower than that of Group III. At the 40th week, the serum insulin value of Group I was significantly higher than that of Group III. From these results, it is suggested that orally administered Zn prevents Cd-induced alterations of liver functions and the regulation of blood glucose in rats.
...
PMID:Effects of zinc on cadmium-induced alterations in hepatic functions and blood glucose of rats. 683 6
The toxic effects of
cadmium
(Cd) and mercury (Hg), as chloride salts, were studied using an hepatic human fetal cell line (WRL-68 cells). From viability curves and the proliferative capacity of the cell in the presence of the metal, three different cell treatments were chosen, (1) 0.5 microM of the metal chloride for 24 h (acute low dose treatment), (2) 0.5 microM of the metal chloride for 7 days (chronic treatment), and (3) 5 microM of the metal chloride for 24 h (acute high dose treatment). WRL-68 cells grown in the presence of Cd exhibited the same proliferative curve as control cells, whereas in the case of Hg, the cells increased their proliferative capacity. Both metals produced ultrastructural alterations in different degrees, mainly observed as mitochondrial and RER structural changes, depending of the treatment and concentration of the metal used. Cytotoxicity was assessed by measuring the release of lactate dehydrogenase from the cells. Acutely high dose-treated cells showed the highest value for this parameter, and Cd-treated cells presented higher lactate dehydrogenase release than the Hg-treated ones. Cell damage was also measured by
alanine aminotransferase
(ALAT) and aspartate aminotransferase (ASAT) activities. Acute high dose Cd treatment caused the highest value of enzymatic release. Lipid peroxidation was significantly different with respect to control cells in chronic and acute high dose treatments with both metals. Metallothionein (MT) induction in response to Hg treatment was not detected. However, a dramatic induction of this protein occurred in Cd-treated cells. WRL-68 cells differentially respond to Cd and Hg making this hepatic fetal human cell line a useful tool in investigating the mechanism of toxicity of these heavy metals.
...
PMID:Cadmium and mercury toxicity in a human fetal hepatic cell line (WRL-68 cells). 748 68
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>